Prejunctional M1 facilitory and M2 inhibitory muscarinic receptors mediate rat bladder contractility

被引:46
作者
Braverman, AS
Kohn, IJ
Luthin, GR
Ruggieri, MR
机构
[1] Temple Univ, Sch Med, Dept Urol, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA
[3] Allegheny Univ Hlth Sci, Philadelphia, PA 19102 USA
关键词
smooth muscle; reverse transcriptase-polymerase chain reaction; acetylcholine;
D O I
10.1152/ajpregu.1998.274.2.R517
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Subtype-selective muscarinic antagonists effects on carbachol-induced and electric field-stimulated contractility of rat bladder were compared in vitro. Schild plot analysis of cumulative carbachol dose-response curves in the presence of antagonists was consistent with M-3-mediated bladder contractions. However, nerve-evoked contractions were inhibited 15% at 30 Hz (P < 0.01) by 10 nM pirenzepine (M-1-selective antagonist), whereas 10 nM methoctramine (M-2-selective antagonist) increased these contractions by 17% at 30 Hz (P < 0.01). Identical doses had no effect on carbachol-induced contractions, indicating prejunctional M-1 facilitory and M-2 inhibitory receptors. m1 Receptors could not be identified by subtype-selective antibodies, nor could the m1 transcript be identified by Northern hybridization. However, m1, m2, m3, and m4 transcripts were identified in rat bladder using the reverse transcriptase-polymerase chain reaction, providing support for the existence of the m1 subtype. In conclusion, strong evidence is provided for the existence of prejunctional M-1 facilitory and M-2 inhibitory and postjunctional M-3 receptors modulating contractility in the rat urinary bladder.
引用
收藏
页码:R517 / R523
页数:7
相关论文
共 30 条
[1]  
ALBERTS P, 1995, J PHARMACOL EXP THER, V274, P458
[2]   IDENTIFICATION OF A FAMILY OF MUSCARINIC ACETYLCHOLINE-RECEPTOR GENES [J].
BONNER, TI ;
BUCKLEY, NJ ;
YOUNG, AC ;
BRANN, MR .
SCIENCE, 1987, 237 (4814) :527-532
[3]   MUSCARINIC RECEPTORS - CHARACTERIZATION, COUPLING AND FUNCTION [J].
CAULFIELD, MP .
PHARMACOLOGY & THERAPEUTICS, 1993, 58 (03) :319-379
[4]  
Choppin A., 1997, Life Sciences, V60, P1193, DOI 10.1016/S0024-3205(97)84358-5
[5]  
DANIEL EE, 1995, J PHARMACOL EXP THER, V275, P978
[6]   ULTRASTRUCTURAL EVIDENCE FOR THE AXONAL LOCALIZATION OF CAUDODORSAL CELL HORMONE MESSENGER-RNA IN THE CENTRAL-NERVOUS-SYSTEM OF THE MOLLUSK LYMNAEA-STAGNALIS [J].
DIRKS, RW ;
VANDORP, AGM ;
VANMINNEN, J ;
FRANSEN, JAM ;
VANDERPLOEG, M ;
RAAP, AK .
MICROSCOPY RESEARCH AND TECHNIQUE, 1993, 25 (01) :12-18
[7]  
DORJE F, 1991, MOL PHARMACOL, V40, P459
[8]   PHARMACOLOGICAL ANALYSIS OF AGONIST-ANTAGONIST INTERACTIONS AT ACETYLCHOLINE MUSCARINIC RECEPTORS IN A NEW URINARY-BLADDER ASSAY [J].
DURANT, PAC ;
SHANKLEY, NP ;
WELSH, NJ ;
BLACK, JW .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (01) :145-150
[9]  
Eglen RM, 1996, PHARMACOL REV, V48, P531
[10]   FUNCTIONAL-ROLE OF M(2) MUSCARINIC RECEPTORS IN THE GUINEA-PIG ILEUM [J].
EHLERT, FJ ;
THOMAS, EA .
LIFE SCIENCES, 1995, 56 (11-12) :965-971